Developing Novel Therapeutics for Oral Cancer Leveraging Drosophila Models

The prevalence of oral squamous cell carcinoma (OSCC) has been increasing worldwide. Surgical resection and chemoradiotherapy are the main OSCC treatments currently, but their effectiveness is limited. One of their major problems is the decline in patients ’ quality of life due to oral dysfunction caused by the extensive resection and oral mucositis. Although targeted therapies have emerged for treating OSCC and have improved the patients’ survival rate, these therapies also cause severe side effects that hamper completion of the regimens.
Source: Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Authors: Source Type: research